| Monograph Title |
Monograph Section |
Scientific Liaison |
| DICLOFENAC SODIUM EXTENDED-RELEASE TABLETS PF 30(2) Pg. 476
|
Title
|
|
| DICLOFENAC SODIUM EXTENDED-RELEASE TABLETS PF 30(2) Pg. 476
|
Definition
|
|
| DICLOFENAC SODIUM EXTENDED-RELEASE TABLETS PF 30(2) Pg. 476
|
Packaging and storage
|
|
| DICLOFENAC SODIUM EXTENDED-RELEASE TABLETS PF 30(2) Pg. 476
|
USP Reference standards
|
|
| DICLOFENAC SODIUM EXTENDED-RELEASE TABLETS PF 30(2) Pg. 476
|
Identification A, B
|
|
| DICLOFENAC SODIUM EXTENDED-RELEASE TABLETS PF 30(2) Pg. 476
|
Uniformity of dosage units
|
|
| DICLOFENAC SODIUM EXTENDED-RELEASE TABLETS PF 30(2) Pg. 476
|
Assay
|
|
| DICLOFENAC SODIUM EXTENDED-RELEASE TABLETS PF 33(2) Pg. 218
|
Labeling
|
|
| DICLOFENAC SODIUM EXTENDED-RELEASE TABLETS PF 33(2) Pg. 218
|
Dissolution <711>
|
|
| DIHYDROCODEINE BITARTRATE PF 33(3) Pg. 396
|
Definition
|
|
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLETS PF 33(2) Pg. 220
|
Dissolution <711>
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Title
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Chemical Info
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Definition
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Packaging and storage
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Labeling
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
USP Reference standards <11>
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Identification
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Specific rotation <781S>
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Water, Method Ia <921>
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Residue on ignition <281>
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Heavy metals, Method II <231>
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Limit of residual solvents
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Limit of 8a-oxo-B1a
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Related compounds
|
|
| EPRINOMECTIN PF 33(1) Pg. 60
|
Assay
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
Title
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
Chemical Info
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
Definition
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
Packaging and storage
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
USP Reference standards <11>
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
Identification
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
Color of solution
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
Specific rotation <781S>
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
Water, Method I <921>
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
Chromatographic purity
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
Enantiomeric purity
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
Content of magnesium
|
|
| ESOMEPRAZOLE MAGNESIUM PF 33(3) Pg. 397
|
Assay
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Title
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Chemical Info
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Definition
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Packaging and storage
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Labeling
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
USP Reference standards <11>
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Identification
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Specific rotation <781S>
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Loss on drying
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Residue on ignition <281>
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Particle size <786>
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Limit of methanol and dichloromethane
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Chromatographic purity
|
|
| ESTRADIOL BENZOATE PF 33(2) Pg. 229
|
Assay
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS CAPSULES PF 33(3) Pg. 477
|
Title
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS CAPSULES PF 33(3) Pg. 477
|
Definition
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS CAPSULES PF 33(3) Pg. 477
|
Packaging and storage
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS CAPSULES PF 33(3) Pg. 477
|
Labeling
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS CAPSULES PF 33(3) Pg. 477
|
USP Reference standards <11>
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS CAPSULES PF 33(3) Pg. 477
|
Identification
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS CAPSULES PF 33(3) Pg. 477
|
Weight variation <2091>
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS CAPSULES PF 33(3) Pg. 477
|
Disintegration and dissolution <2040>
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS CAPSULES PF 33(3) Pg. 477
|
Content of Fish oil
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS CAPSULES PF 33(3) Pg. 477
|
Content of EPA and DHA and Content of total omega-3 acids
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS CAPSULES PF 33(3) Pg. 477
|
Other requirements
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Title
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Definition
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Packaging and storage
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Labeling
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
USP Reference Standards
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Identification
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Acid Value
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Anisidine value
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Peroxide value
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Total oxidation value
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Unsaponifiable matter
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Stearin
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Absorbance
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Limit of Arsenic
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Limit of Lead
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Limit of Cadmium
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Limit of Mercury
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Limit of dioxins, furans and polychlorinated biphenyls (PCBs)
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Content of EPA and DHA
|
|
| FISH OIL CONTAINING OMEGA-3 ACIDS PF 33(3) Pg. 471
|
Content of total omega-3 acids
|
|
| FLUCONAZOLE PF 33(3) Pg. 400
|
Related compounds
|
|
| FLUDARABINE PHOSPHATE INJECTION PF 33(2) Pg. 232
|
Title
|
|
| FLUDARABINE PHOSPHATE INJECTION PF 33(2) Pg. 232
|
Definition
|
|
| FLUDARABINE PHOSPHATE INJECTION PF 33(2) Pg. 232
|
Packaging and storage
|
|
| FLUDARABINE PHOSPHATE INJECTION PF 33(2) Pg. 232
|
USP Reference standards <11>
|
|
| FLUDARABINE PHOSPHATE INJECTION PF 33(2) Pg. 232
|
Identification
|
|
| FLUDARABINE PHOSPHATE INJECTION PF 33(2) Pg. 232
|
Bacterial endotoxins <85>
|
|
| FLUDARABINE PHOSPHATE INJECTION PF 33(2) Pg. 232
|
Sterility <71>
|
|
| FLUDARABINE PHOSPHATE INJECTION PF 33(2) Pg. 232
|
pH <791>
|
|
| FLUDARABINE PHOSPHATE INJECTION PF 33(2) Pg. 232
|
Particulate matter <788>
|
|
| FLUDARABINE PHOSPHATE INJECTION PF 33(2) Pg. 232
|
Related compounds
|
|
| FLUDARABINE PHOSPHATE INJECTION PF 33(2) Pg. 232
|
Other requirements
|
|
| FLUDARABINE PHOSPHATE INJECTION PF 33(2) Pg. 232
|
Assay
|
|
| FLUMAZENIL INJECTION PF 33(2) Pg. 234
|
Bacterial endotoxins <85>
|
|
| FOSINOPRIL SODIUM TABLETS PF 33(3) Pg. 405
|
Dissolution <711>
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
Title
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
Chemical Info
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
Definition
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
Packaging and storage
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
USP Reference standards <11>
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
Identification
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
Loss on drying <731>
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
Residue on ignition <281>
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
Heavy metals, Method II <231>
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
Limit of palladium
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
Limit of 4R,8R stereoisomer
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
Related compounds
|
|
| GALANTAMINE HYDROBROMIDE PF 33(2) Pg. 234
|
Assay
|
|
| GALANTAMINE TABLETS PF 33(3) Pg. 407
|
Title
|
|
| GALANTAMINE TABLETS PF 33(3) Pg. 407
|
Definition
|
|
| GALANTAMINE TABLETS PF 33(3) Pg. 407
|
Packaging and storage
|
|
| GALANTAMINE TABLETS PF 33(3) Pg. 407
|
USP Reference standards <11>
|
|
| GALANTAMINE TABLETS PF 33(3) Pg. 407
|
Identification
|
|
| GALANTAMINE TABLETS PF 33(3) Pg. 407
|
Dissolution <711>
|
|
| GALANTAMINE TABLETS PF 33(3) Pg. 407
|
Uniformity of dosage units <905>
|
|
| GALANTAMINE TABLETS PF 33(3) Pg. 407
|
Related compounds
|
|
| GALANTAMINE TABLETS PF 33(3) Pg. 407
|
Assay
|
|
| GINGER PF 33(3) Pg. 478
|
Definition
|
|
| GINGER PF 33(3) Pg. 478
|
Packaging and storage
|
|
| GINGER PF 33(3) Pg. 478
|
Botanic characteristics
|
|
| GLIMEPIRIDE TABLETS PF 33(3) Pg. 411
|
Title
|
|
| GLIMEPIRIDE TABLETS PF 33(3) Pg. 411
|
Definition
|
|
| GLIMEPIRIDE TABLETS PF 33(3) Pg. 411
|
Packaging and storage
|
|
| GLIMEPIRIDE TABLETS PF 33(3) Pg. 411
|
USP Reference standards <11>
|
|
| GLIMEPIRIDE TABLETS PF 33(3) Pg. 411
|
Identification
|
|
| GLIMEPIRIDE TABLETS PF 33(3) Pg. 411
|
Uniformity of dosage units <905>
|
|
| GLIMEPIRIDE TABLETS PF 33(3) Pg. 411
|
Related compounds
|
|
| GLIMEPIRIDE TABLETS PF 33(3) Pg. 411
|
Assay
|
|
| HYDROGENATED POLYDECENE PF 33(3) Pg. 485
|
Title
|
|
| HYDROGENATED POLYDECENE PF 33(3) Pg. 485
|
Chemical Info
|
|
| HYDROGENATED POLYDECENE PF 33(3) Pg. 485
|
Definition
|
|
| HYDROGENATED POLYDECENE PF 33(3) Pg. 485
|
Packaging and storage
|
|
| HYDROGENATED POLYDECENE PF 33(3) Pg. 485
|
Labeling
|
|
| HYDROGENATED POLYDECENE PF 33(3) Pg. 485
|
Identification
|
|
| HYDROGENATED POLYDECENE PF 33(3) Pg. 485
|
Specific gravity <841>
|
|
| HYDROGENATED POLYDECENE PF 33(3) Pg. 485
|
Viscosity <911>
|
|
| HYDROGENATED POLYDECENE PF 33(3) Pg. 485
|
Readily carbonizable substances <271>
|
|
| HYDROGENATED POLYDECENE PF 33(3) Pg. 485
|
Limit of nickel
|
|
| HYDROGENATED POLYDECENE PF 33(3) Pg. 485
|
Limit of short-chain hydrocarbons
|
|
| HYDROGENATED POLYDECENE PF 33(3) Pg. 485
|
Content of decene oligomer
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
Title
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
Chemical Info
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
Definition
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
Packaging and storage
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
USP Reference standards <11>
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
Identification
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
pH <791>
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
Water, Method I <921>
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
Residue on ignition <281>
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
Heavy metals, Method II <231>
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
Limit of ipratropium related compound A
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
Related compounds
|
|
| IPRATROPIUM BROMIDE PF 33(2) Pg. 241
|
Assay
|
|
| ISOSORBIDE MONONITRATE EXTENDED-RELEASE TABLETS PF 32(6) Pg. 1703
|
Labeling
|
|
| ISOSORBIDE MONONITRATE EXTENDED-RELEASE TABLETS PF 32(6) Pg. 1703
|
Dissolution <711>
|
|
| ISOSORBIDE MONONITRATE EXTENDED-RELEASE TABLETS PF 32(6) Pg. 1703
|
Dissolution <711>
|
|
| ISOSORBIDE MONONITRATE EXTENDED-RELEASE TABLETS PF 32(6) Pg. 1703
|
Dissolution <711>
|
|
| ISOSORBIDE MONONITRATE TABLETS PF 33(3) Pg. 413
|
Dissolution <711>
|
|
| LETROZOLE TABLETS PF 33(2) Pg. 244
|
Related compounds
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(1) Pg. 75
|
Title
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(1) Pg. 75
|
Chemical Info
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(1) Pg. 75
|
Definition
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(1) Pg. 75
|
Packaging and storage
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(1) Pg. 75
|
USP Reference standards <11>
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(1) Pg. 75
|
Identification
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(1) Pg. 75
|
pH <791>
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(1) Pg. 75
|
Water, Method Ic <921>
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(1) Pg. 75
|
Residue on ignition <281>
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(1) Pg. 75
|
Heavy metals, Method I <231>
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(1) Pg. 75
|
Enantiomeric purity and chiral identity
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(1) Pg. 75
|
Assay
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(3) Pg. 416
|
Microbial limits <61>
|
|
| LEVALBUTEROL HYDROCHLORIDE PF 33(3) Pg. 416
|
Enantiomeric purity and chiral identity
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(1) Pg. 79
|
Title
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(1) Pg. 79
|
Definition
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(1) Pg. 79
|
Packaging and storage
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(1) Pg. 79
|
Labeling
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(1) Pg. 79
|
USP Reference standards <11>
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(1) Pg. 79
|
Identification
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(1) Pg. 79
|
Uniformity of dosage units <905>
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(1) Pg. 79
|
pH <791>
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(1) Pg. 79
|
Particulate matter <788>
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(1) Pg. 79
|
Enantiomeric purity and chiral identity
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(1) Pg. 79
|
Assay
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(1) Pg. 79
|
Osmolality
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(3) Pg. 420
|
Particulate matter <788>
|
|
| LEVALBUTEROL INHALATION SOLUTION PF 33(3) Pg. 420
|
Enantiomeric purity and chiral identity
|
|
| LEVOTHYROXINE SODIUM PF 33(3) Pg. 422
|
Definition
|
|
| LEVOTHYROXINE SODIUM PF 33(3) Pg. 422
|
Identification
|
|
| LEVOTHYROXINE SODIUM PF 33(3) Pg. 422
|
Water, Method III <921>
|
|
| LEVOTHYROXINE SODIUM PF 33(3) Pg. 422
|
Water, Method I <921>
|
|
| LEVOTHYROXINE SODIUM PF 33(3) Pg. 422
|
Limit of inorganic iodides
|
|
| LEVOTHYROXINE SODIUM PF 33(3) Pg. 422
|
Limit of liothyronine sodium
|
|
| LEVOTHYROXINE SODIUM PF 33(3) Pg. 422
|
Related compounds
|
|
| LEVOTHYROXINE SODIUM PF 33(3) Pg. 422
|
Assay
|
|
| LIOTHYRONINE SODIUM PF 33(3) Pg. 426
|
Identification
|
|
| LIOTHYRONINE SODIUM PF 33(3) Pg. 426
|
Limit of inorganic iodide
|
|
| LIOTHYRONINE SODIUM PF 33(3) Pg. 426
|
Limit of levothyroxine sodium
|
|
| LIOTHYRONINE SODIUM PF 33(3) Pg. 426
|
Assay
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
Title
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
Definition
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
Packaging and storage
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
Labeling
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
USP Reference standards
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
Fatty acid composition
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
pH
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
Globule size limits
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
Particulate matter
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
Limit of free fatty acid
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
Other requirements
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
Assay
|
|
| LIPID INJECTABLE EMULSION PF 32(2) Pg. 350
|
Bacterial endotoxins
|
|
| LORAZEPAM PF 33(3) Pg. 427
|
USP Reference standards <11>
|
|
| LORAZEPAM PF 33(3) Pg. 427
|
Identification
|
|
| LORAZEPAM PF 33(3) Pg. 427
|
Related compounds
|
|
| LORAZEPAM PF 33(3) Pg. 427
|
Assay
|
|
| LORAZEPAM TABLETS PF 33(3) Pg. 429
|
Related compounds
|
|
| LUTEIN PF 33(2) Pg. 255
|
Residue on ignition <281>
|
|
| LUTEIN PF 33(2) Pg. 255
|
Zeaxanthin and other related compounds
|
|
| LUTEIN PF 33(2) Pg. 255
|
Content of lutein
|
|
| LUTEIN PREPARATION PF 33(2) Pg. 255
|
Definition
|
|
| LUTEIN PREPARATION PF 33(2) Pg. 255
|
Water, Method I <921>
|
|
| LUTEIN PREPARATION PF 33(2) Pg. 255
|
Residue on ignition <281>
|
|
| LUTEIN PREPARATION PF 33(2) Pg. 255
|
Heavy metals, Method II <231>
|
|
| LUTEIN PREPARATION PF 33(2) Pg. 255
|
Zeaxanthin and other related compounds
|
|
| LUTEIN PREPARATION PF 33(2) Pg. 255
|
Content of lutein
|
|
| MARITIME PINE EXTRACT PF 32(4) Pg. 1142
|
Identification
|
|
| MARITIME PINE EXTRACT PF 32(4) Pg. 1142
|
Microbial enumeration <2021>
|
|
| MARITIME PINE EXTRACT PF 32(4) Pg. 1142
|
Content of procyanidins
|
|
| MARITIME PINE PF 32(4) Pg. 1140
|
Identification
|
|
| MARITIME PINE PF 32(4) Pg. 1140
|
Content of procyanidins
|
|
| MECLIZINE HYDROCHLORIDE PF 33(2) Pg. 244
|
Chromatographic purity
|
|
| MECLIZINE HYDROCHLORIDE TABLETS PF 33(2) Pg. 245
|
Identification
|
|
| MECLIZINE HYDROCHLORIDE TABLETS PF 33(2) Pg. 245
|
Dissolution, Procedure for a Pooled Sample <711>
|
|
